Alpha Wave Global’s Abiomed Inc ABMD Stock Holding History

Alpha Wave Global’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-82,625	Closed	-$20M	–	52
2020 Q2	$20M	Buy	+82,625	New	+$16.6M	1.78%	20

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha Wave Global's ABMD Position: Q3 2020 in Review

Alpha Wave Global sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 82,625 shares — an estimated $20M sold.

Alpha Wave Global first reported a position in ABMD in Q2 2020 and held it in 1 quarter. The position peaked at $20M in Q2 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

Alpha Wave Global reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
Alpha Wave Global sold 82,625 Abiomed Inc shares in Q3 2020, an estimated $20M.
Alpha Wave Global first reported a position in Abiomed Inc in Q2 2020 and held it in 1 quarter.
Alpha Wave Global's Abiomed Inc position peaked at $20M in Q2 2020.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Alpha Wave Global's 13F filing for Q3 2020, filed 16 Nov 2020.